AO
ABBV icon

Advisor OS’s AbbVie ABBV Stock Holding History

Advisor OS’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.65M Sell
22,462
-10
-0% -$2.15K 0.38% 46
2026
Q1 		$4.89M Buy
22,472
+1,459
+7% +$324K 0.35% 47
2025
Q4 		$4.8M Buy
21,013
+3,332
+19% +$759K 0.39% 42
2025
Q3 		$4.09M Buy
17,681
+870
+5% +$177K 0.35% 40
2025
Q2 		$3.12M Buy
16,811
+412
+3% +$76.6K 0.31% 51
2025
Q1 		$3.44M Buy
16,399
+1,331
+9% +$259K 0.39% 42
2024
Q4 		$2.68M Sell
15,068
-419
-3% -$77K 0.31% 60
2024
Q3 		$3.06M Buy
15,487
+1,070
+7% +$200K 0.3% 58
2024
Q2 		$2.47M Buy
14,417
+215
+2% +$35.6K 0.27% 65
2024
Q1 		$2.59M Buy
14,202
+1,024
+8% +$176K 0.3% 62
2023
Q4 		$2.04M Buy
13,178
+516
+4% +$75.2K 0.27% 71
2023
Q3 		$1.89M Buy
12,662
+1,514
+14% +$222K 0.28% 64
2023
Q2 		$1.5M Sell
11,148
-6,827
-38% -$1M 0.25% 75
2023
Q1 		$2.86M Sell
17,975
-168
-0.9% -$25.7K 0.69% 31
2022
Q4 		$2.93M Buy
18,143
+3,602
+25% +$552K 0.78% 29
2022
Q3 		$1.95M Sell
14,541
-265
-2% -$38K 0.59% 38
2022
Q2 		$2.27M Buy
14,806
+612
+4% +$93.5K 0.66% 33
2022
Q1 		$2.3M Sell
14,194
-1,044
-7% -$152K 0.67% 30
2021
Q4 		$2.06M Buy
15,238
+910
+6% +$107K 0.42% 61
2021
Q3 		$1.55M Buy
14,328
+369
+3% +$42.2K 0.34% 68
2021
Q2 		$1.57M Buy
13,959
+2,557
+22% +$288K 0.33% 60
2021
Q1 		$1.24M Buy
11,402
+1,011
+10% +$108K 0.28% 69
2020
Q4 		$1.11M Buy
10,391
+5,450
+110% +$524K 0.3% 48
2020
Q3 		$433K Sell
4,941
-2,015
-29% -$190K 0.18% 61
2020
Q2 		$683K Buy
+6,956
New +$612K 0.41% 51

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Advisor OS's ABBV Position: Q2 2026 in Review

Advisor OS reduced its AbbVie (ABBV) stake by 0.04% in Q2 2026, selling an estimated $2.15K and leaving 22,462 shares worth $5.65M. The position accounts for 0.38% of the portfolio, ranked #46.

Advisor OS first reported a position in ABBV in Q2 2020 and has held it in 25 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Advisor OS held 22,462 shares of AbbVie worth $5.65M as of Q2 2026.
  • Advisor OS sold 10 AbbVie shares in Q2 2026, an estimated $2.15K.
  • AbbVie made up 0.38% of Advisor OS's portfolio in Q2 2026, its #46 holding.
  • Advisor OS first reported a position in AbbVie in Q2 2020 and has held it in 25 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Advisor OS's 13F filing for Q2 2026, filed 5 Aug 2026.